114 related articles for article (PubMed ID: 25969367)
1. IgE and risk of cancer in 37 747 individuals from the general population.
Helby J; Bojesen SE; Nielsen SF; Nordestgaard BG
Ann Oncol; 2015 Aug; 26(8):1784-90. PubMed ID: 25969367
[TBL] [Abstract][Full Text] [Related]
2. Prediagnostic immunoglobulin E levels and risk of chronic lymphocytic leukemia, other lymphomas and multiple myeloma-results of the European Prospective Investigation into Cancer and Nutrition.
Nieters A; Łuczyńska A; Becker S; Becker N; Vermeulen R; Overvad K; Aleksandrova K; Boeing H; Lagiou P; Trichopoulos D; Trichopoulou A; Krogh V; Masala G; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita B; Jeurnink SM; Weiderpass E; Ardanaz E; Chirlaque MD; Sánchez MJ; Sánchez S; Borgquist S; Butt S; Melin B; Späth F; Rinaldi S; Brennan P; Kelly RS; Riboli E; Vineis P; Kaaks R
Carcinogenesis; 2014 Dec; 35(12):2716-22. PubMed ID: 25269801
[TBL] [Abstract][Full Text] [Related]
3. No evidence for anticipation in lymphoproliferative tumors in population-based samples.
Daugherty SE; Pfeiffer RM; Mellemkjaer L; Hemminki K; Goldin LR
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1245-50. PubMed ID: 15894680
[TBL] [Abstract][Full Text] [Related]
4. Melanoma in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma.
Famenini S; Martires KJ; Zhou H; Xavier MF; Wu JJ
J Am Acad Dermatol; 2015 Jan; 72(1):78-84. PubMed ID: 25440434
[TBL] [Abstract][Full Text] [Related]
5. Ultraviolet radiation exposure and risk of malignant lymphomas.
Smedby KE; Hjalgrim H; Melbye M; Torrång A; Rostgaard K; Munksgaard L; Adami J; Hansen M; Porwit-MacDonald A; Jensen BA; Roos G; Pedersen BB; Sundström C; Glimelius B; Adami HO
J Natl Cancer Inst; 2005 Feb; 97(3):199-209. PubMed ID: 15687363
[TBL] [Abstract][Full Text] [Related]
6. Increased incidence and recurrence rates of nonmelanoma skin cancer in patients with non-Hodgkin lymphoma: a Rochester Epidemiology Project population-based study in Minnesota.
Brewer JD; Shanafelt TD; Khezri F; Sosa Seda IM; Zubair AS; Baum CL; Arpey CJ; Cerhan JR; Call TG; Roenigk RK; Smith CY; Weaver AL; Otley CC
J Am Acad Dermatol; 2015 Feb; 72(2):302-9. PubMed ID: 25479909
[TBL] [Abstract][Full Text] [Related]
7. Atopy and risk of non-Hodgkin lymphoma.
Melbye M; Smedby KE; Lehtinen T; Rostgaard K; Glimelius B; Munksgaard L; Schöllkopf C; Sundström C; Chang ET; Koskela P; Adami HO; Hjalgrim H
J Natl Cancer Inst; 2007 Jan; 99(2):158-66. PubMed ID: 17227999
[TBL] [Abstract][Full Text] [Related]
8. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
Chang TW; Weaver AL; Shanafelt TD; Habermann TM; Wriston CC; Cerhan JR; Call TG; Brewer JD
Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851
[TBL] [Abstract][Full Text] [Related]
9. Evidence of an association between non-Hodgkin's lymphoma and skin cancer.
Adami J; Frisch M; Yuen J; Glimelius B; Melbye M
BMJ; 1995 Jun; 310(6993):1491-5. PubMed ID: 7787593
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia.
Beguin Y; Lampertz S; De Groote D; Igot D; Malaise M; Fillet G
Leukemia; 1993 Dec; 7(12):2019-25. PubMed ID: 8255102
[TBL] [Abstract][Full Text] [Related]
11. Low plasma lycopene concentration is associated with increased mortality in a cohort of patients with prior oral, pharynx or larynx cancers.
Mayne ST; Cartmel B; Lin H; Zheng T; Goodwin WJ
J Am Coll Nutr; 2004 Feb; 23(1):34-42. PubMed ID: 14963051
[TBL] [Abstract][Full Text] [Related]
12. Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia.
Cerhan JR; Vachon CM; Habermann TM; Ansell SM; Witzig TE; Kurtin PJ; Janney CA; Zheng W; Potter JD; Sellers TA; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1466-71. PubMed ID: 12433728
[TBL] [Abstract][Full Text] [Related]
13. Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.
Velez NF; Karia PS; Vartanov AR; Davids MS; Brown JR; Schmults CD
JAMA Dermatol; 2014 Mar; 150(3):280-7. PubMed ID: 24429548
[TBL] [Abstract][Full Text] [Related]
14. Secondary myeloma in patients with chronic lymphoblastic leukemia: A case report and analysis of data from SEER database.
Lin Z; Chen X; Huang Y; Zhao H; Li Z; Xu B
Curr Probl Cancer; 2021 Oct; 45(5):100728. PubMed ID: 33752897
[TBL] [Abstract][Full Text] [Related]
15. The Association of Dyslipidemia With Chronic Lymphocytic Leukemia: A Population-Based Study.
Mozessohn L; Earle C; Spaner D; Cheng SY; Kumar M; Buckstein R
J Natl Cancer Inst; 2017 Mar; 109(3):. PubMed ID: 27754925
[TBL] [Abstract][Full Text] [Related]
16. Trends in hematological cancer in the elderly in Denmark, 1980-2012.
Ocias LF; Larsen TS; Vestergaard H; Friis LS; Abildgaard N; Frederiksen H;
Acta Oncol; 2016; 55 Suppl 1():98-107. PubMed ID: 26783877
[TBL] [Abstract][Full Text] [Related]
17. Cancer incidence in the rural community of Tecumseh, Michigan: a pattern of increased lymphopoietic neoplasms.
Waterhouse D; Carman WJ; Schottenfeld D; Gridley G; McLean S
Cancer; 1996 Feb; 77(4):763-70. PubMed ID: 8616770
[TBL] [Abstract][Full Text] [Related]
18. [Inheritance in lymphoproliferative disorders].
Jønsson V; Olsen JH
Ugeskr Laeger; 2006 Jun; 168(24):2361-6. PubMed ID: 16822421
[TBL] [Abstract][Full Text] [Related]
19. Dietary fish intake and risk of leukaemia, multiple myeloma, and non-Hodgkin lymphoma.
Fritschi L; Ambrosini GL; Kliewer EV; Johnson KC;
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):532-7. PubMed ID: 15066916
[TBL] [Abstract][Full Text] [Related]
20. Gradual increase of chronic lymphocytic leukemia incidence in Korea, 1999-2010: comparison to plasma cell myeloma.
Lee SJ; Tien HF; Park HJ; Kim JA; Lee DS
Leuk Lymphoma; 2016; 57(3):585-9. PubMed ID: 26133722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
